ClinicalTrials.gov
public full text
Public Domain
Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study
The purpose of this research study is to determine whether a short-term administration of an investigational study drug may provide evidence of improvement in cognitive functioning in a group of stable male subjects with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia#875471
- Add On Treatment for Cognitive Deficits in Schizophrenia#1173864
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication#810236
- Take it personally: Promoting a personalised neuroscience informed approach to cognitive rehabilitation following psychopathology.#1169003
- Take it personally: Promoting a personalised neuroscience informed approach to cognitive rehabilitation following psychopathology.#1167820
Record · ID 850873
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive